DaVita Inc.
DaVita Inc. (NYSE: DVA) is a $11.6B medical - care facilities company trading at $181.66 — 18.5× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 05:07 UTC.
DaVita Inc. (NYSE: DVA) is a $11.6B medical - care facilities company trading at $181.66 — 18.5× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 05:07 UTC.
DaVita Inc. is a healthcare company that provides kidney care services across multiple settings and stages of kidney disease. The company operates a U.S. dialysis business treating patients with end-stage kidney disease, international dialysis operations in multiple countries, and a U.S. integrated kidney care business that manages patients under risk-based arrangements. DaVita's care model emphasizes patient choice and comprehensive kidney services, supported by clinical teams including nephrologists, nurses, dietitians, and other healthcare professionals.
Summarized from DaVita Inc.’s SEC filings · Read the filing ↗
| Quote | |
| Price | $181.66 |
| Market cap | $11.6B |
| 52-week range | $148.00 – $247.49 |
| Valuation | |
| P/E (TTM) | 18.46× |
| EV/EBITDA | 7.70× |
| EPS (TTM) | $9.84 |
| Return on equity | -114.70% |
| Returns | |
| 52-week return | +22.7% |
DaVita Inc. is a medical - care facilities company, listed on NYSE as DVA.
DVA trades at $181.66, 18.46× trailing earnings, 7.70× EV/EBITDA, as of 2026-09-04.
DaVita Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-08. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 05:07 UTC. This page is also available as JSON at /api/data?ticker=DVA and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for DVA and 5,000+ tickers.
Create a free account — keep DVAGET /api/data?ticker=DVA
This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt